SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

J.B.Chemicals & Pharmaceuticals informs about analyst meet

27 Jan 2022 Evaluate
J.B.Chemicals & Pharmaceuticals has informed that the Company has scheduled a conference call for investors and analysts on Thursday, January 27, 2022 at 3.30 pm IST to discuss the Acquisition of Brands and Related Assets from Sanzyme.

The above information is a part of company’s filings submitted to BSE.

JB Chem & Pharma Share Price

2486.85 29.25 (1.19%)
14-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1940.15
Dr. Reddys Labs. 1245.75
Cipla 1438.55
Zydus Lifesciences 1133.85
Lupin 2469.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: